FLOW CYTOMETRIC ANALYSIS OF EPSTEIN-BARR-VIRUS (EBV) LATENT MEMBRANE-PROTEIN EXPRESSION IN EBV-INFECTED RAJI CELLS

被引:14
|
作者
BOOS, H
STOEHR, M
SAUTER, M
MUELLERLANTZSCH, N
机构
[1] UNIV SAARLAND,INST MED MIKROBIOL & HYG,VIROL ABT,W-6650 HOMBURG,GERMANY
[2] UNIV FREIBURG,INST MED MIKROBIOL & IMMUNOL,VIROL ABT,W-7800 FREIBURG,GERMANY
[3] GERMAN CANC RES CTR,INST EXPTL PATHOL,W-6900 HEIDELBERG 1,GERMANY
来源
关键词
D O I
10.1099/0022-1317-71-8-1811
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In cultures of the latently Epstein-Barr virus (EBV)-infected Burkitt's lymphoma cell line Raji, the detectable amount of the EBV-encoded latent membrane protein (LMP) is transiently increased after addition of fresh nutrient medium containing foetal calf serum. In the current study, the relative amount of LMP and DNA in Raji cells was determined by biparametric flow cytometry analysis at different times after the addition of fresh medium with 10% foetal calf serum to a dense Raji culture. A transient increase in the proportion of LMP-positive cells was observed during the lag phase of the culture. Subsequently, a subpopulation of cells, which had been arrested in the G0 or G1 phase, simultaneously started to progress through the cell cycle. Neither the amount of LMP in the cells, nor the enhanced expression of LMP, was restricted to a certain phase of the cell cycle. Further analysis revealed that the number of LMP-positive cells proceeding simultaneously from the G1 to the S phase of the cell cycle is about the same as the total number of cells changing phases. These results suggest that LMP expression might be one step in the pathway leading to growth activation of resting cells in cultures of the immortalized Raji cell line.
引用
收藏
页码:1811 / 1815
页数:5
相关论文
共 50 条
  • [31] SEQUENCE POLYMORPHISM IN THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN (LMP)-2 GENE
    BUSSON, P
    EDWARDS, RH
    TURSZ, T
    RAABTRAUB, N
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 139 - 145
  • [32] EXPRESSION OF THE EPSTEIN-BARR-VIRUS (EBV)-ENCODED MEMBRANE-PROTEIN LMP1 IMPAIRS THE INVITRO GROWTH, CLONABILITY AND TUMORIGENICITY OF AN EBV-NEGATIVE BURKITT-LYMPHOMA LINE
    CUOMO, L
    RAMQUIST, T
    TRIVEDI, P
    WANG, F
    KLEIN, G
    MASUCCI, MG
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (06) : 949 - 955
  • [33] The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells
    Forte, Eleonora
    Salinas, Raul E.
    Chang, Christina
    Zhou, Ting
    Linnstaedt, Sarah D.
    Gottwein, Eva
    Jacobs, Cassandra
    Jima, Dereje
    Li, Qi-Jing
    Dave, Sandeep S.
    Luftig, Micah A.
    JOURNAL OF VIROLOGY, 2012, 86 (12) : 6889 - 6898
  • [34] Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction
    Yang, LX
    Aozasa, K
    Oshimi, K
    Takada, K
    CANCER RESEARCH, 2004, 64 (15) : 5332 - 5337
  • [35] MONOCLONAL-ANTIBODIES TO THE LATENT MEMBRANE-PROTEIN OF EPSTEIN-BARR-VIRUS REVEAL HETEROGENEITY OF THE PROTEIN AND INDUCIBLE EXPRESSION IN VIRUS-TRANSFORMED CELLS
    ROWE, M
    EVANS, HS
    YOUNG, LS
    HENNESSY, K
    KIEFF, E
    RICKINSON, AB
    JOURNAL OF GENERAL VIROLOGY, 1987, 68 : 1575 - 1586
  • [36] Shift in Epstein-Barr virus (EBV)-infected cells in chronic active EBV disease
    Sakaki, Shinichiro
    Imadome, Ken-Ichi
    Kawano, Fuyuko
    Nakadate, Hisaya
    Ishiguro, Akira
    PEDIATRICS INTERNATIONAL, 2019, 61 (08) : 825 - 826
  • [37] EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 INDUCES EXPRESSION OF THE VIRUS-ENCODED LATENT MEMBRANE-PROTEIN
    ABBOT, SD
    ROWE, M
    CADWALLADER, K
    RICKSTEN, A
    GORDON, J
    WANG, F
    RYMO, L
    RICKINSON, AB
    JOURNAL OF VIROLOGY, 1990, 64 (05) : 2126 - 2134
  • [38] DOWN REGULATION OF CLASS-I HLA ANTIGENS AND OF THE EPSTEIN-BARR-VIRUS (EBV)-ENCODED LATENT MEMBRANE-PROTEIN (LMP) IN BURKITT-LYMPHOMA LINES
    MASUCCI, MG
    TORSTEINSDOTTIR, S
    COLOMBANI, J
    BRAUTBAR, C
    KLEIN, E
    KLEIN, G
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (03) : 320 - 320
  • [39] Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood
    Shatzer, Amber
    Ali, Mir A.
    Chavez, Mayra
    Dowdell, Kennichi
    Lee, Min-Jung
    Tomita, Yusuke
    El-Hariry, Iman
    Trepel, Jane B.
    Proia, David A.
    Cohen, Jeffrey I.
    LEUKEMIA & LYMPHOMA, 2017, 58 (04) : 923 - 931
  • [40] Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin
    Hsu, CH
    Hergenhahn, M
    Chuang, SE
    Yeh, PY
    Wu, TC
    Gao, M
    Cheng, AL
    ANTICANCER RESEARCH, 2002, 22 (6C) : 4065 - 4071